Relapse of Alopecia Areata During Ongoing JAK Inhibitor Therapy Is Not Uncommon and Usually Occurs in Previously Affected Areas: A Multicentre Italian Real-World Study.

Published: 13 June 2026| Version 1 | DOI: 10.17632/tprw6ktnwr.1
Contributors:
Andrea Sechi, Luca Rapparini, Luca Valtellini, Francesca Pampaloni, Stephano Cedirian, Francesca Bruni, Federico Quadrelli, Ginevra Martelli, Mauro Barbareschi, Francesca Ambrogio, Caterina Foti, Dall’Oglio Federica, Francesco Lacarrubba, Giuseppe Micali, Ketty Peris, Giacomo Caldarola, Lorenzo Maria Pinto, Laura Diluvio, Luca Bianchi, Alessandra Narcisi, Luigi Gargiulo, Carlo Vignoli, Emanuele Trovato, Elisa Cinotti, Pietro Rubegni, Francesca Prignano, Gianmarco Silvi, Lorenzo Ala, Alfredo Rossi, Giovanni Pellacani, Giuseppe Gallo, Isotta Giunipero di Corteranzo, simone ribero, Calogero Pagliarello, Riccardo Balestri, Oriana Simonetti, Edoardo De Simoni, Raffaele Dante Caposiena Caro, Iris Zalaudek, Laura Atzori, Silvia Sanna, Maria Vastarella , Valentina Dini, Flavia Manzo Margiotta, Graziella Babino, Alessandro Borghi, Natale Schettini, Maria Esposito, Lina Maria Magnanimi, Franco Rongioletti, Gianmarco Diego Bigotto, Francesco Bellinato , Elisabetta Fulgione, Mariateresa Cantelli, Angelo Valerio Marzano, Bianca Maria Piraccini, Michela Starace

Description

The Supplementary Material provides the complete list of the Alopecia Areata Relapse Study Group members and affiliations, together with extended methodological details, additional results, statistical analyses, discussion, and study limitations supporting the findings reported in the main manuscript.

Files

Categories

Hair Disorder, Alopecia Areata

Licence